Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis.
about
Coronary microvascular dysfunction, microvascular angina, and treatment strategies.Coronary Microvascular Dysfunction, Microvascular Angina, and Management.Cardiac MRI assessment of myocardial perfusion.Advances in stress cardiac MRI and computed tomography.Advances in parametric mapping with CMR imagingMyocardial perfusion: near-automated evaluation from contrast-enhanced MR images obtained at rest and during vasodilator stress.Emerging MRI methods in translational cardiovascular researchPET/MRI: current state of the art and future potential for cardiovascular applications.MRI and CT in the diagnosis of coronary artery disease: indications and applications.Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging.Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment.Quantitative pixel-wise measurement of myocardial blood flow: the impact of surface coil-related field inhomogeneity and a comparison of methods for its correction.Comparison of the Diagnostic Performance of Four Quantitative Myocardial Perfusion Estimation Methods Used in Cardiac MR Imaging: CE-MARC SubstudyA quantitative high resolution voxel-wise assessment of myocardial blood flow from contrast-enhanced first-pass magnetic resonance perfusion imaging: microsphere validation in a magnetic resonance compatible free beating explanted pig heart model.A Comparison of Theory-Based and Experimentally Determined Myocardial Signal Intensity Correction Methods in First-Pass Perfusion Magnetic Resonance ImagingStress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings.Quantitative three-dimensional myocardial perfusion cardiovascular magnetic resonance with accurate two-dimensional arterial input function assessment.Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenosonEmpirical mathematical model for dynamic manganese-enhanced MRI of the murine pancreas for assessment of β-cell function.Evaluation of an automated method for arterial input function detection for first-pass myocardial perfusion cardiovascular magnetic resonance.Investigation into diagnostic accuracy of common strategies for automated perfusion motion correction.Inter-observer agreement and diagnostic accuracy of myocardial perfusion reserve quantification by cardiovascular magnetic resonance at 3 Tesla in comparison to quantitative coronary angiographyPerfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease.Quantitative assessment of myocardial blood flow in coronary artery disease by cardiovascular magnetic resonance: comparison of Fermi and distributed parameter modeling against invasive methods.Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.Voxel-wise quantification of myocardial blood flow with cardiovascular magnetic resonance: effect of variations in methodology and validation with positron emission tomography.Analysis of spatiotemporal fidelity in quantitative 3D first-pass perfusion cardiovascular magnetic resonance.Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole.Free-breathing cardiac MR stress perfusion with real-time slice tracking.Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging.Cardiovascular magnetic resonance imaging in ischemic heart disease.Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography.Myocardial perfusion distribution and coronary arterial pressure and flow signals: clinical relevance in relation to multiscale modeling, a review.Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies.Cardiac MR perfusion imaging: where we are.Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease.Measurement and modeling of coronary blood flow.Quantification of myocardial blood flow using non-electrocardiogram-triggered MRI with three-slice coverage.
P2860
Q26861073-2A4CBAF0-88A2-41D7-81FC-AC28D043A445Q30277875-368F54AA-8185-4BD3-B556-959DC8D324E4Q30407701-606797B6-8A6A-4329-AC45-A9B0D4F2F28DQ30412128-CDCE1083-399E-4FE1-B283-1DFDEBC0F37FQ30412201-8A16D6A8-9DE4-4970-AC61-CF6A4CBF4CB7Q30416669-0B5E999D-B27B-4166-AF11-45440E993AF7Q30425743-52C46856-33CF-4163-8831-7B7CD701A1DCQ30456937-645535AC-FE8F-4E70-B2FB-3D32C8DF9325Q30470368-925D3E33-0922-4946-81C6-ADFFA058B8C9Q33627699-C97519A4-D284-46F5-B3F4-5B9D6B1CC7A7Q33741484-893AFF41-3674-48C9-B061-5C3EF91D4E49Q34293709-3FD36EBD-686B-4126-87EF-B6A0C95727D7Q35068455-C3AA0828-A7C1-46F1-9DEA-A2C886858728Q35683420-C9E5D157-07CA-4C73-9A58-3C5C9D8E8BD6Q36061574-0B892D89-BA77-4C72-8494-7CF045E48C3DQ36160355-77967AD9-35B2-41CA-8082-E256FECD422DQ36325926-7C526804-7D1C-46D4-B3C6-A1A34278FE80Q36346706-1789D985-F888-4DA3-825C-F355054C1BEEQ36510139-B9D769F4-95D1-464B-9410-BD1FE7C658A6Q36555852-DABCAD5E-5D7A-4A61-84A9-8D191EDAC98CQ36640165-0AB0B76C-4DF6-40E5-9C29-DAF5235F85CCQ36778986-5867EC76-83F7-4F52-9839-01ED69A50600Q36896816-AA547A46-4B88-4B89-99D2-0BFA69A79524Q37000952-C61EED99-7B2B-4B74-8A05-23DFC9DD60EBQ37105989-5F6BB7C2-11CA-4414-8A8D-00B97888EA75Q37254811-8B68C6B4-B9E9-467F-A80E-A4FA2D914BAEQ37425510-21BBE8F1-55B9-41DA-ABF3-CCF7278F20B0Q37524613-3F0E5717-7A37-477B-8A10-127852C9023FQ37609884-28F4A47E-EB58-47E9-A39B-3A990918BE1BQ37616354-803B1344-F287-40A0-95C9-E90080548D96Q37691900-42787E9E-7D17-44A4-930B-5F947724923AQ37965658-B15EBBD0-2820-4D95-9B9E-615D5E0BDABAQ38018564-92CE1BD2-C698-4F39-B19D-BD00E46E6E42Q38122622-106A1213-AD6F-4769-B989-B54B4CE2BB23Q38124722-61F3A372-69E8-4AA9-94AA-DCC050648520Q38201582-D09E107E-4117-4980-A305-3B34BC8955C1Q38230320-5BFBCF91-BD0C-44D0-B97B-4F9B6123D01CQ38263600-0EC0B116-A8FA-4F8A-85DE-382DCA59D25DQ38540388-37A9E7D0-8EF0-4879-B6D7-BF333415EBD6Q38618730-61D54843-AF4E-41B8-BAE7-E4CE85BBDFCE
P2860
Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessment of advanced coronar ...... resonance perfusion analysis.
@ast
Assessment of advanced coronar ...... resonance perfusion analysis.
@en
type
label
Assessment of advanced coronar ...... resonance perfusion analysis.
@ast
Assessment of advanced coronar ...... resonance perfusion analysis.
@en
prefLabel
Assessment of advanced coronar ...... resonance perfusion analysis.
@ast
Assessment of advanced coronar ...... resonance perfusion analysis.
@en
P2093
P2860
P50
P1476
Assessment of advanced coronar ...... resonance perfusion analysis.
@en
P2093
Amy M West
John Christopher
Kiran R Nandalur
Patrick F Antkowiak
Vishal Arora
P2860
P304
P356
10.1016/J.JACC.2010.02.061
P407
P577
2010-08-01T00:00:00Z